Abstract
Long-term, curative treatment of cutaneous T-cell lymphomas (CTCL) remains a major challenge. Therapy resistance is often based on apoptosis deficienc......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
